Maxim Group Downgrades PainReform to Hold
Portfolio Pulse from Benzinga Newsdesk
Maxim Group has downgraded PainReform (NASDAQ:PRFX) from a Buy to a Hold rating, as per analyst Naz Rahman.
October 24, 2024 | 1:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Maxim Group has downgraded PainReform from a Buy to a Hold rating, indicating a less optimistic outlook on the stock.
The downgrade from Buy to Hold by Maxim Group suggests a less favorable view on PainReform's stock, which could lead to a negative short-term impact on its price as investors may adjust their positions based on this new rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100